Exploiting a unique, naturally occurring germline mutation in patients with the NF1 tumor predisposition syndrome who fail to develop neurofibromas or optic gliomas (Arg1809Cys), we employed hiPSCs and genetically engineered mice to identify two distinct mechanisms underlying neuronal activity regulation of nervous system tumor progression (Fig. 8). The gene discussed is NF1; the disease is neoplasm.